MedPath

Woodward Pharma Services LLC

Woodward Pharma Services LLC logo
🇺🇸United States
Ownership
Private
Established
2015-01-01
Employees
1
Market Cap
-
Website
https://www.woodwardpharma.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

24

FDA:24

Drug Approvals

SODIUM ACETATE

Approval Date
Nov 1, 2023
FDA

Pyridostigmine Bromide

Approval Date
Oct 13, 2023
FDA

Coreg

Approval Date
Apr 25, 2023
FDA

CARBOPROST TROMETHAMINE

Approval Date
Apr 11, 2023
FDA

KETOROLAC TROMETHAMINE

Approval Date
Jan 25, 2023
FDA

SODIUM PHENYLACETATE and SODIUM BENZOATE

Approval Date
Jan 10, 2023
FDA

TABLOID

Approval Date
Dec 29, 2022
FDA

MYLERAN

Approval Date
Dec 29, 2022
FDA

LEUKERAN

Approval Date
Dec 29, 2022
FDA

AVODART

Approval Date
Dec 15, 2022
FDA
  • Prev
  • 1
  • 2
  • 3
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.